Period:
Draw Mode:
| Volume | 49,359 |
|
|||||
| News | - | ||||||
| Day High | 0.6839 | Low High |
|||||
| Day Low | 0.63 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NeuroMetrix Inc | NURO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0212 | -3.2% | 0.641 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.673 | 0.63 | 0.6839 | 0.641 | 0.6622 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 159 | 49,359 | $ 0.6620374 | $ 32,678 | - | 0.63 - 3.45 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:01:04 | 10 | $ 0.641 | USD |
NeuroMetrix Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.5M | 8.58M | - | 8.26M | -4.42M | -0.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NeuroMetrix News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NURO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.71 | 0.75 | 0.63 | 0.6632513 | 58,125 | -0.069 | -9.72% |
| 1 Month | 0.6938 | 0.7999 | 0.63 | 0.6996053 | 40,266 | -0.0528 | -7.61% |
| 3 Months | 0.97 | 1.00 | 0.63 | 0.8325163 | 47,841 | -0.329 | -33.92% |
| 6 Months | 1.48 | 1.505 | 0.63 | 0.9810522 | 73,381 | -0.839 | -56.69% |
| 1 Year | 3.00 | 3.45 | 0.63 | 1.91 | 186,087 | -2.36 | -78.63% |
| 3 Years | 1.52 | 38.75 | 0.63 | 11.01 | 1,382,478 | -0.879 | -57.83% |
| 5 Years | 1.31 | 38.75 | 0.2518 | 9.78 | 960,325 | -0.669 | -51.07% |
NeuroMetrix Description
| NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables. |